Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06346392
What this trial is testing

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
AstraZeneca 594
Testing effectiveness (Phase 2)UnknownNCT00005607
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
Robert H. Lurie Cancer Center
Not applicableUnknownNCT05249244
What this trial is testing

A Real World Study of the Treatment of Gastric Adenocarcinoma With Huachansu

Who this might be right for
Gastric Adenocarcinoma
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT03219593
What this trial is testing

Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric CancerApatinibBiomarker
The First Affiliated Hospital of Bengbu Medical University 30
Early research (Phase 1)Ended earlyNCT05252416
What this trial is testing

(VELA) Study of BLU-222 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHR+ Breast CancerCCNE1 Amplification+6 more
Blueprint Medicines Corporation 50
Testing effectiveness (Phase 2)Study completedNCT00719550
What this trial is testing

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric CancerEsophageal Cancer
Amgen 130
Testing effectiveness (Phase 2)Looking for participantsNCT07026149
What this trial is testing

Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06925243
What this trial is testing

Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 682
Testing effectiveness (Phase 2)Looking for participantsNCT06829797
What this trial is testing

Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined With SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Shandong Provincial Hospital 96
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Not applicableActive Not RecruitingNCT06728358
What this trial is testing

The Future Management of Patients With Neoplasms of the Gastro-intestinal Tract

Who this might be right for
Pancreatic AdenocarcinomaCholangiocarcinomaColon Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Early research (Phase 1)Looking for participantsNCT04999761
What this trial is testing

AB122 Platform Study

Who this might be right for
Advanced or Metastatic Solid TumorPancreatic Ductal AdenocarcinomaColorectal Cancer+6 more
Taiho Pharmaceutical Co., Ltd. 917
Testing effectiveness (Phase 2)UnknownNCT06321913
What this trial is testing

Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Harbin Medical University 25
Large-scale testing (Phase 3)UnknownNCT01917552
What this trial is testing

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Who this might be right for
Gastric Cancer
Asan Medical Center 870
Testing effectiveness (Phase 2)Ended earlyNCT04510285
What this trial is testing

A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection

Who this might be right for
Esophagogastric TumorsGastric CancerGastric Tumor+7 more
Memorial Sloan Kettering Cancer Center 1
Not applicableStudy completedNCT04602026
What this trial is testing

The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer

Who this might be right for
Adult Liver CarcinomaGastric CarcinomaMalignant Solid Neoplasm+1 more
Ohio State University Comprehensive Cancer Center 66
Not applicableLooking for participantsNCT07441785
What this trial is testing

Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer

Who this might be right for
Gastric Cancer (GC)Siewert Type III Adenocarcinoma of Esophagogastric JunctionSiewert Type II Adenocarcinoma of Esophagogastric Junction
P. Herzen Moscow Oncology Research Institute 400
Large-scale testing (Phase 3)Study completedNCT00548548
What this trial is testing

Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer

Who this might be right for
Adenocarcinoma
Genentech, Inc. 774
Not applicableStudy completedNCT02629315
What this trial is testing

Carnoy's Solution Versus Formalin in Rectal and Gastric Cancer Specimens Following: a Randomized Trial

Who this might be right for
Rectal CancerGastric Adenocarcinoma
Instituto do Cancer do Estado de São Paulo 130
Not applicableActive Not RecruitingNCT06504615
What this trial is testing

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)+1 more
Bristol-Myers Squibb 208
Next Page